The study investigated the effectiveness of the use of the drugs Devivit Carnitine and Carnivet-L as part of symptomatic therapy for hepatodystrophy in lactating cows. Devivit Carnitine is a complex preparation that contains carnitine hydrochloride, vitamins E and B12, methionine, selenium, and zinc. The combined action of these components provides a general tonic and metabolic effect, which is especially important in cases of liver dysfunction, intoxication, postpartum complications, decreased appetite, and general exhaustion in animals. It was established that the combination of medicinal treatment and feeding with high-quality feed contributes to the restoration of liver function and the normalization of metabolic processes in the animals’ bodies. By the fifth day of treatment, the morbidity rate in the first experimental group decreased to 28.6 %, which was 7.1 % lower than in the second experimental group. By the tenth day, the cows had fully recovered. Clinical and biochemical studies showed that, prior to treatment, the animals had decreased concentrations of total hemoglobin, erythrocytes, total protein, albumins, and urea, and increased levels of leukocytes, bilirubin, and the activity of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), indicating impaired liver function. Against the background of the use of Devivit Carnitine and Carnivet-L, a statistically significant (P < 0.05) improvement in morphological and biochemical parameters was observed: increases in the number of erythrocytes, levels of hemoglobin, protein fractions, and urea by 15.4–33.6 %, and decreases in bilirubin levels and ALT and AST activity by 47.0–58.2 %. The obtained results indicate the high therapeutic effectiveness of both drugs in the complex treatment of cattle with hepatodystrophy. Based on their impact on blood parameters and the speed of clinical recovery, Devivit Carnitine demonstrated slightly higher efficacy compared to Carnivet-L, which allows it to be recommended as an effective agent in the comprehensive therapy of hepatodystrophy in cows.